Trillium Therapeutics Introduces Industry Postdoctoral Fellowship Program
TORONTO, ONTARIO -- (Marketwired) -- 08/31/16 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TR), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today that the company has established an …